ACTA FAC MED NAISS 2008; 25 (4): 189-193 |
Original article
RECURRENT INTESTINAL CANDIDOSIS
Suzana Tasic1,2
Natasa Miladinovic-Tasic1,2
Jovana Djordjevic1
Dragan Zdravkovic2,
Drenka Paunovic-Todosijevic2
1Faculty of Medicine University of Nis, Serbia
2Public Health Institute Nis, Serbia
SUMMARY
The prevalence of recurrent intestinal candidosis
(RIC) has been increasing in recent years.
The aim of the study was to investigate the prevalence of some Candida species
in etiology of RIC and to examine their antifungal susceptibility.
The study involved 70 patients with RIC. The patients were selected according to
criteria that in the previous six months they had minimum two microbiological
findings of the same Candida species in feces, as well as the symptoms and
clinical signs of the digestive tract infection (nausea, disgust, borborygmus,
bloating, mushy stool, appearance of mucus in feces). Candida spp. were isolated
using a standard procedure. Candida albicans was (C. albicans) identified from
other species by the germination test application. Non-albicans species were
differentiated using a commercial CandiFast-test (Mycoplasma-International,
France).
After using the tests for yeast differentiation, C. albicans was found to be the
most frequent cause of recurrent intestinal tract candidosis (45 patients -
64.29%). Other species were found in a significantly smaller number of patients
(C. glabrata-4, C. crusei-4, C. kefyr-3, C. parapsilosis-1, C. guillermondil-1,
C. tropicalis-1, C. lusiniae-1). The isolated yeasts showed good susceptibility
to amphotericin B, nystatine, 5-fluorocytosine and ketoconazole, while higher
percent of isolated species was resistant to econazole, miconazole and
fluconazole.
Species C. albicans is the most common cause of RIC.
Key words: recurrent intestinal candidosis, antifungal susceptibility,
Candida spp.